# TAURIGA SCIENCES, INC.

TAURIGA SCIENCES, INC. is a company headquartered in Wappingers Falls, NY, United States.

## Company overview

- **Legal name:** TAURIGA SCIENCES, INC.
- **Former names in filing history:** Immunovative, Inc. (2012-06-29 to 2013-04-08); Novo Energies Corp (2009-06-26 to 2012-03-29); ATLANTIC WINE AGENCIES INC (2004-06-29 to 2009-05-21); ATLANTICWINE AGENCIES INC (2004-02-17 to 2004-06-02); NEW ENGLAND ACQUISITIONS INC (2001-09-25 to 2004-02-12)
- **Classification:** Company
- **Industry (SIC):** 2833 — Medicinal Chemicals & Botanical Products
- **Headquarters:** Wappingers Falls, NY, United States
- **Incorporated in:** FL
- **Fiscal year end:** March 31
- **SEC CIK:** 0001142790

## About

TAURIGA SCIENCES, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001142790, and its reported industry is Medicinal Chemicals & Botanical Products. In 10-K filed on 2021-06-29, it reported annual revenue of USD 285,319; net income of USD -3,626,446; total assets of USD 2,488,703 for the fiscal period ended 2021-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-03-31)

- **Revenue:** $285,319 (USD 285,319)
- **Net income:** -$3.6M (USD -3,626,446)
- **Total assets:** $2.5M (USD 2,488,703)
- **Cash and equivalents:** $49,826 (USD 49,826)
- **Operating cash flow:** -$2.6M (USD -2,554,578)

### FY2020 (period ended 2020-03-31)

- **Revenue:** $234,389 (USD 234,389)
- **Net income:** -$3.0M (USD -3,033,290)
- **Total assets:** $643,462 (USD 643,462)
- **Cash and equivalents:** $5,348 (USD 5,348)
- **Operating cash flow:** -$1.5M (USD -1,510,562)

### FY2019 (period ended 2019-03-31)

- **Revenue:** $57,134 (USD 57,134)
- **Net income:** -$1.1M (USD -1,097,439)
- **Total assets:** $960,826 (USD 960,826)
- **Cash and equivalents:** $385,943 (USD 385,943)
- **Operating cash flow:** -$328,585 (USD -328,585)

### FY2018 (period ended 2018-03-31)

- **Revenue:** $1,188 (USD 1,188)
- **Net income:** -$36,127 (USD -36,127)
- **Total assets:** $688,838 (USD 688,838)
- **Cash and equivalents:** $12,291 (USD 12,291)
- **Operating cash flow:** $259,834 (USD 259,834)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 10-Q — filed 2022-02-16 — period 2021-12-31
- Form 8-K — filed 2021-11-23 — period 2021-11-22
- Form 10-Q — filed 2021-11-15 — period 2021-09-30
- Form DEF 14A — filed 2021-10-12 — period 2021-10-12
- Form 8-K — filed 2021-09-22 — period 2021-09-20
- Form 10-Q — filed 2021-08-16 — period 2021-06-30
- Form 10-K/A — filed 2021-08-16 — period 2021-03-31
- Form 8-K — filed 2021-07-23 — period 2021-07-23
- Form 10-K — filed 2021-06-29 — period 2021-03-31
- Form 8-K — filed 2021-03-08 — period 2021-03-08
- Form 8-K — filed 2021-03-05 — period 2021-02-26
- Form 10-Q — filed 2021-02-22 — period 2020-12-31

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/tauriga-sciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology